Literature DB >> 8699850

Neutrophil degranulation related to the reperfusion of ischemic human heart during cardiopulmonary bypass.

P Dhôte-Burger1, A Vuilleminot, T Lecompte, C Pasquier, L Bara, P Julia, C Chardigny, J N Fabiani.   

Abstract

Activation of polymorphonuclear neutrophils (PMNs) during cardiopulmonary bypass (CPB) is a wellknown phenomenon. This study aimed to determine if activated PMNs are sequestered and degranulated within the myocardium at reperfusion in patients undergoing coronary artery bypass grafting (CABG). Nineteen patients undergoing elective CABG were included in a prospective randomized study. Blood samples were obtained simultaneously from the radial artery (RA) and the coronary sinus (CS) at the following times: T0 (5 min after onset of CPB), T1 (2 min after aortic unclamping), and T2 (10 min after aortic unclamping). Neutrophil function was evaluated by PMN count and by elastase and lactoferrin concentrations. All patients survived. Neutrophils increased significantly from T0 to T1 and T2 in both RA and CS (p < 0.001 between T0 and T1 or T2). Pre-ischemia and reperfusion were associated with a significantly lower neutrophil count in CS compared with RA blood (p < 0.001), suggesting that PMNs were trapped within the myocardium at the onset of the CPB. Elastase and lactoferrin concentrations increased significantly from T0 to T1 and from T1 to T2 for each site, with greater concentrations (p < 0.001) in the CS compared with the RA, suggesting that activated neutrophils released their granular content into the plasma milieu only after reperfusion of the ischemic heart. This study establishes that neutrophil sequestration seems to be secondary to PMN activation by CPB but that the ischemia-reperfusion sequence induces specific degranulation of the PMNs trapped within the ischemic myocardium.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8699850     DOI: 10.1097/00005344-199500252-00026

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  5 in total

Review 1.  MicroRNAs as Potential Pharmaco-targets in Ischemia-Reperfusion Injury Compounded by Diabetes.

Authors:  Hassan Dehaini; Hussein Awada; Ahmed El-Yazbi; Fouad A Zouein; Khodr Issa; Assaad A Eid; Maryam Ibrahim; Adnan Badran; Elias Baydoun; Gianfranco Pintus; Ali H Eid
Journal:  Cells       Date:  2019-02-12       Impact factor: 6.600

2.  Role of tumour necrosis factor-alpha and other cytokines in ischemia-reperfusion-induced injury in the heart.

Authors:  Harjot K Saini; Yan-Jun Xu; Ming Zhang; Peter P Liu; Lorrie A Kirshenbaum; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2005

3.  Therapeutic potentials of pentoxifylline for treatment of cardiovascular diseases.

Authors:  Ming Zhang; Yan-Jun Xu; Shushma A Mengi; Amarjit S Arneja; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2004

4.  Integrated Bioinformatics Analysis and Verification of Gene Targets for Myocardial Ischemia-Reperfusion Injury.

Authors:  Jianru Wang; Xiaohui Li; Guangcao Peng; Genhao Fan; Mengmeng Zhang; Jian Chen
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-15       Impact factor: 2.650

Review 5.  Mechanisms of oxidative stress and myocardial protection during open-heart surgery.

Authors:  Nikolaos G Baikoussis; Nikolaos A Papakonstantinou; Chrysoula Verra; Georgios Kakouris; Maria Chounti; Panagiotis Hountis; Panagiotis Dedeilias; Michalis Argiriou
Journal:  Ann Card Anaesth       Date:  2015 Oct-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.